Caltech eClub Q&A - Richard Lizambri

The Caltech Entrepreneurship Club would like to invite you to a question and answer session with Richard Lizambri, the Director of Clinical Research for Hematology and Oncology at Amgen. During the past 6 years with Amgen, Richard has worked on the clinical development of a number of biologic therapeutic molecules including growth factors and monoclonal antibodies.

Dr. Lizambri will relate his experiences in clinical drug development at a number of different size biotech companies as well as his experience on the regulatory side at the FDA at this next eClub Q&A session at 2:00 pm on Tuesday, October 18th in Schlinger 101.

Please RSVP via the form below if you plan on attending--space is limited. https://docs.google.com/spreadsheet/viewform?hl=en_US&formkey=dDZyU1NoZGhEdE15VnUxaDhNX25vYlE6MQ#gid=0